Status:
COMPLETED
A Nomogram for Predicting the Diagnosis of Central Malignant Tumors Based on Preoperative Clinical Characteristics and Laboratory Indicators:
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Central Malignant Tumors
PCNSL
Eligibility:
All Genders
Brief Summary
The purpose of this study is to develop a nomogram to predict the diagnostic probability of preoperative central lymphoma and glioma, as well as the diagnostic probability of glioblastoma and non glio...
Detailed Description
this study aimed to develop and validate a novel diagnostic model, based on a large cohort of clinical data, for accurate differentiation between PCNSL and glioma, and GBM and non-GBM. the Ethics Rev...
Eligibility Criteria
Inclusion
- \- Patients who underwent surgical treatment and were diagnosed with PNCSL or glioma after surgery;
Exclusion
- \- Patients who have not undergone their first surgery
Key Trial Info
Start Date :
September 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT06914700
Start Date
September 1 2016
End Date
December 1 2024
Last Update
April 9 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.